CSW Industrials CEO Armes sells 1,500 shares
CSW Industrials, Inc. Chairman, President & CEO Joseph B. Armes sold 1,500 common shares on October 15, 2026, at a weighted average price of $287.0384 per share under a 10b5-1 trading plan established August 12, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CSW Industrials, Inc. Chairman, President & CEO Joseph B. Armes sold 1,500 common shares on October 15, 2026, at a weighted average price of $287.0384 per share under a 10b5-1 trading plan established August 12, 2025. The shares were sold in multiple transactions at prices from $284.59 to $288.72, inclusive. Armes directly held 64,083 shares after the sale. His reported holdings also included 3,219 common shares held indirectly by ESOP, performance rights tied to 9,836, 8,004, 8,236 and 9,186 underlying shares, and 19,685 restricted stock units.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 1,500 shares
Net Sell
7 txns
Insider
Armes Joseph B
Role
Chairman, President & CEO
Sold
1,500 shs ($431K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 1,500 | $287.0384 | $431K |
| holding | Performance Rights F3 | -- | -- | -- |
| holding | Performance Rights F4 | -- | -- | -- |
| holding | Performance Rights F5 | -- | -- | -- |
| holding | Performance Rights F6 | -- | -- | -- |
| holding | Restricted Stock Units F7 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 64,083 shares (Direct);
Performance Rights — 35,262 contracts (Direct);
Restricted Stock Units — 19,685 contracts (Direct);
Common Stock — 3,219 shares (Indirect, by ESOP)
Footnotes (7)
- F1. The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- F2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $284.59 to $288.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 250% during a three-year performance cycle beginning on April 1, 2026 and ending on March 31, 2029 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F4. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F5. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F6. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200%, during a performance cycle beginning April 1, 2021 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- F7. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Key Figures
Common shares sold: 1,500 shares
Weighted average sale price: $287.0384 per share
Sale price range: $284.59–$288.72 per share
+3 more
6 metrics
Common shares sold
1,500 shares
October 15, 2026
Weighted average sale price
$287.0384 per share
Sales on October 15, 2026
Sale price range
$284.59–$288.72 per share
Multiple transactions; inclusive
Direct common shares after sale
64,083 shares
After the October 15, 2026 sale
Common shares held indirectly by ESOP
3,219 shares
Reported as of October 15, 2026
Restricted stock units
19,685 units
Reported as of October 15, 2026
Key Terms
10b5-1 trading plan, performance right, relative total shareholder return, restricted stock unit
4 terms
10b5-1 trading plan regulatory
"effected pursuant to a 10b5-1 trading plan"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
performance right financial
"Each performance right represents a contingent right to receive one share"
restricted stock unit financial
"Each restricted stock unit represents a contingent right"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What performance rights did CSW's CEO report?
Armes reported four performance-right positions tied to 9,836, 8,004, 8,236 and 9,186 underlying common shares. Their respective performance cycles end on March 31, 2029, March 31, 2028, March 31, 2027 and March 31, 2027. Vesting is based on CSW's relative total shareholder return compared with the Russell 2000 Index; the issuer may settle them in cash or common shares.
How do CSW's CEO's reported restricted stock units vest?
The 19,685 restricted stock units each represent a contingent right to one common share at vesting. Forty percent vest no earlier than April 26, 2025, upon the successful recruitment and hiring of a successor CEO; the remaining 60% vest upon that successor's successful first employment anniversary.
AI-generated analysis. How Rhea-AI works. Not financial advice.
